Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics

.

Source: World Journal of Biological Psychiatry - June 16, 2020 Category: Psychiatry Authors: Marc-Andr é Nolin Marie-France Demers Chlo é Rauzier Roch-Hugo Bouchard Camille Cadrin Jean-Pierre Despr és Marc-Andr é Roy Natalie Alm éras Fr édéric Picard Source Type: research